Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1995 1
1996 3
1997 1
1998 1
1999 1
2001 2
2002 2
2003 1
2005 1
2006 1
2007 1
2010 1
2011 2
2013 1
2014 3
2015 1
2016 2
2017 4
2018 1
2019 1
2020 2
2021 4
2022 2
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
Alicic RZ, Rooney MT, Tuttle KR. Alicic RZ, et al. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045. doi: 10.2215/CJN.11491116. Epub 2017 May 18. Clin J Am Soc Nephrol. 2017. PMID: 28522654 Free PMC article.
The natural history of diabetic kidney disease includes glomerular hyperfiltration, progressive albuminuria, declining GFR, and ultimately, ESRD. Metabolic changes associated with diabetes lead to glomerular hypertrophy, glomerulosclerosis, and tubulointerstitial in …
The natural history of diabetic kidney disease includes glomerular hyperfiltration, progressive albuminuria, declining GFR, and ultimately, …
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
D'Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M, Praga M. D'Agati VD, et al. Nat Rev Nephrol. 2016 Aug;12(8):453-71. doi: 10.1038/nrneph.2016.75. Epub 2016 Jun 6. Nat Rev Nephrol. 2016. PMID: 27263398 Review.
The prevalence of obesity-related glomerulopathy is increasing in parallel with the worldwide obesity epidemic. Glomerular hypertrophy and adaptive focal segmental glomerulosclerosis define the condition pathologically. ...
The prevalence of obesity-related glomerulopathy is increasing in parallel with the worldwide obesity epidemic. Glomerular hypertr …
Management of diabetic kidney disease: where do we stand?: A narrative review.
Sindhu D, Sharma GS, Kumbala D. Sindhu D, et al. Medicine (Baltimore). 2023 Mar 31;102(13):e33366. doi: 10.1097/MD.0000000000033366. Medicine (Baltimore). 2023. PMID: 37000108 Free PMC article. Review.
The pathogenesis and risk factors for the development of diabetic kidney disease are complex and multifaceted, resulting in glomerular hypertrophy, tubulointerstitial inflammation, and fibrosis. ...
The pathogenesis and risk factors for the development of diabetic kidney disease are complex and multifaceted, resulting in glomerular …
Simple obesity and renal function.
Sikorska D, Grzymislawska M, Roszak M, Gulbicka P, Korybalska K, Witowski J. Sikorska D, et al. J Physiol Pharmacol. 2017 Apr;68(2):175-180. J Physiol Pharmacol. 2017. PMID: 28614766 Free article. Review.
This so-called obesity-related glomerulopathy is characterized at early stages by glomerular hypertrophy with or without secondary focal segmental glomerulosclerosis. ...
This so-called obesity-related glomerulopathy is characterized at early stages by glomerular hypertrophy with or without secon …
Adiponectin for the treatment of diabetic nephropathy.
Lee JY, Yang JW, Han BG, Choi SO, Kim JS. Lee JY, et al. Korean J Intern Med. 2019 May;34(3):480-491. doi: 10.3904/kjim.2019.109. Epub 2019 Apr 30. Korean J Intern Med. 2019. PMID: 31048658 Free PMC article. Review.
Thus, prevention of glomerular hypertrophy and attenuation of glomerular hyperfiltration may have therapeutic potential for diabetic nephropathy (DN). ...Moreover, the recently developed adiponectin receptor agonist, AdipoRon, shows therapeutic potential for DN. In …
Thus, prevention of glomerular hypertrophy and attenuation of glomerular hyperfiltration may have therapeutic potential for di …
Clinicopathological characteristics of high-altitude polycythemia-related kidney disease in Tibetan inhabitants.
Wang H, Tang C, Dang Z, Yong A, Liu L, Wang S, Zhao M. Wang H, et al. Kidney Int. 2022 Jul;102(1):196-206. doi: 10.1016/j.kint.2022.03.027. Epub 2022 May 2. Kidney Int. 2022. PMID: 35513124
Twelve patients had hyperuricemia, nine had hypertension, and three had kidney insufficiency. On histopathology, glomerular hypertrophy, glomerular basement membrane thickening, podocyte foot process effacement, segmental glomerulosclerosis and global glomeruloscler …
Twelve patients had hyperuricemia, nine had hypertension, and three had kidney insufficiency. On histopathology, glomerular hypert …
Endocan levels in children with renal hypodysplasia.
Cayci FS, Aydin Z, Aygar IS, Avci B, Inozu M, Aksoy OY, Bayrakci US. Cayci FS, et al. Clin Nephrol. 2021 Jun;95(6):332-337. doi: 10.5414/CN110402. Clin Nephrol. 2021. PMID: 33704056
AIMS: Severe reduction in nephron numbers that are characteristic of renal hypodysplasia (RHD) are one of the cause of childhood chronic kidney disease (CKD). Glomerular hyperfiltration, glomerular hypertrophy, progressive glomerular scarring, and interstitial fibro …
AIMS: Severe reduction in nephron numbers that are characteristic of renal hypodysplasia (RHD) are one of the cause of childhood chronic kid …
Obesity and renal disease.
Adelman RD. Adelman RD. Curr Opin Nephrol Hypertens. 2002 May;11(3):331-5. doi: 10.1097/00041552-200205000-00010. Curr Opin Nephrol Hypertens. 2002. PMID: 11981264 Review.
The pathophysiology of obesity-associated proteinuria is unclear but may include hyperfiltration, increased renal venous pressure, glomerular hypertrophy, hyperlipidemia and increased synthesis of vasoactive and fibrogenic substances, including angiotensin II, insul …
The pathophysiology of obesity-associated proteinuria is unclear but may include hyperfiltration, increased renal venous pressure, glomer …
Clinical and Pathological Features of Renal Presentations in Polycythemia Vera.
Yang J, Yu X, Hu N, Su T. Yang J, et al. Am J Med Sci. 2022 Jan;363(1):33-41. doi: 10.1016/j.amjms.2021.10.009. Epub 2021 Oct 21. Am J Med Sci. 2022. PMID: 34687616
The pathological diagnosis was IgA nephropathy in three, non-IgA mesangial proliferative glomerulopathy in one, and glomerular hypertrophy with ischemic renal injury in one patient. Glomerular ischemia, ischemic shrinkage, focal segmental sclerosis, and glomerulomeg …
The pathological diagnosis was IgA nephropathy in three, non-IgA mesangial proliferative glomerulopathy in one, and glomerular hyp …
Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
Castellino P, Shohat J, DeFronzo RA. Castellino P, et al. Semin Nephrol. 1990 May;10(3):228-41. Semin Nephrol. 1990. PMID: 2190280 Review.
The potential mechanisms by which glomerular hypertrophy can lead to renal histologic damage were discussed previously. By increasing the luminal diameter, glomerular hypertrophy also would be expected to augment wall tension and thereby increase intra …
The potential mechanisms by which glomerular hypertrophy can lead to renal histologic damage were discussed previously. By inc …
49 results